Literature DB >> 28088462

Activation of the Hypoxia Inducible Factor 1α Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol Gallstones.

Yoichiro Asai1, Tetsuya Yamada2, Sohei Tsukita1, Kei Takahashi1, Masamitsu Maekawa3, Midori Honma1, Masanori Ikeda4, Keigo Murakami5, Yuichiro Munakata1, Yuta Shirai1, Shinjiro Kodama1, Takashi Sugisawa1, Yumiko Chiba1, Yasuteru Kondo6, Keizo Kaneko1, Kenji Uno1, Shojiro Sawada1, Junta Imai1, Yasuhiro Nakamura5, Hiroaki Yamaguchi3, Kozo Tanaka4, Hironobu Sasano5, Nariyasu Mano3, Yoshiyuki Ueno7, Tooru Shimosegawa6, Hideki Katagiri8.   

Abstract

BACKGROUND & AIMS: Hypoxia-inducible factor 1α subunit (HIF1A) is a transcription factor that controls the cellular response to hypoxia and is activated in hepatocytes of patients with nonalcoholic fatty liver disease (NAFLD). NAFLD increases the risk for cholesterol gallstone disease by unclear mechanisms. We studied the relationship between HIF1A and gallstone formation associated with liver steatosis.
METHODS: We performed studies with mice with inducible disruption of Hif1a in hepatocytes via a Cre adenoviral vector (inducible hepatocyte-selective HIF1A knockout [iH-HIFKO] mice), and mice without disruption of Hif1a (control mice). Mice were fed a diet rich in cholesterol and cholate for 1 or 2 weeks; gallbladders were collected and the number of gallstones was determined. Livers and biliary tissues were analyzed by histology, quantitative reverse-transcription polymerase chain reaction, immunohistochemistry, and immunoblots. We measured concentrations of bile acid, cholesterol, and phospholipid in bile and rates of bile flow. Primary hepatocytes and cholangiocytes were isolated and analyzed. HIF1A was knocked down in Hepa1-6 cells with small interfering RNAs. Liver biopsy samples from patients with NAFLD, with or without gallstones, were analyzed by quantitative reverse-transcription polymerase chain reaction.
RESULTS: Control mice fed a diet rich in cholesterol and cholate developed liver steatosis with hypoxia; levels of HIF1A protein were increased in hepatocytes around central veins and 90% of mice developed cholesterol gallstones. Only 20% of the iH-HIFKO mice developed cholesterol gallstones. In iH-HIFKO mice, the biliary lipid concentration was reduced by 36%, compared with control mice, and bile flow was increased by 35%. We observed increased water secretion from hepatocytes into bile canaliculi to mediate these effects, resulting in suppression of cholelithogenesis. Hepatic expression of aquaporin 8 (AQP8) protein was 1.5-fold higher in iH-HIFKO mice than in control mice. Under hypoxic conditions, cultured hepatocytes increased expression of Hif1aHmox1, and Vegfa messenger RNAs (mRNAs), and down-regulated expression of AQP8 mRNA and protein; AQP8 down-regulation was not observed in cells with knockdown of HIF1A. iH-HIFKO mice had reduced inflammation and mucin deposition in the gallbladder compared with control mice. Liver tissues from patients with NAFLD with gallstones had increased levels of HIF1A, HMOX1, and VEGFA mRNAs, compared with livers from patients with NAFLD without gallstones.
CONCLUSIONS: In steatotic livers of mice, hypoxia up-regulates expression of HIF1A, which reduces expression of AQP8 and concentrates biliary lipids via suppression of water secretion from hepatocytes. This promotes cholesterol gallstone formation. Livers from patients with NAFLD and gallstones express higher levels of HIF1A than livers from patients with NAFLD without gallstones.
Copyright © 2017 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aquaporin-8; Gallstone; Hypoxia; NAFLD

Mesh:

Substances:

Year:  2017        PMID: 28088462     DOI: 10.1053/j.gastro.2017.01.001

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  14 in total

Review 1.  An update on the pathogenesis of cholesterol gallstone disease.

Authors:  Agostino Di Ciaula; David Q-H Wang; Piero Portincasa
Journal:  Curr Opin Gastroenterol       Date:  2018-03       Impact factor: 3.287

Review 2.  Mouse models of gallstone disease.

Authors:  Tony Y Wang; Piero Portincasa; Min Liu; Patrick Tso; David Q-H Wang
Journal:  Curr Opin Gastroenterol       Date:  2018-03       Impact factor: 3.287

3.  Association Study Between Polymorphic Loci in Cholesterol Metabolism Pathway and Gallstone in the Tibetan Population.

Authors:  Lifeng Ma; Hui Chen; Zhiying Zhang; Lijun Liu; Yiduo Zhao; Yansong Li; Zhipeng Zhao; Haitao Chen; Longli Kang
Journal:  Front Genet       Date:  2022-05-16       Impact factor: 4.772

Review 4.  Hypoxia signaling in human health and diseases: implications and prospects for therapeutics.

Authors:  Zhen Luo; Mingfu Tian; Ge Yang; Qiaoru Tan; Yubing Chen; Geng Li; Qiwei Zhang; Yongkui Li; Pin Wan; Jianguo Wu
Journal:  Signal Transduct Target Ther       Date:  2022-07-07

5.  Investigate of AQP gene expression in the liver of mice after ischemia-reperfusion.

Authors:  Solmaz Karimi; Saeid Reza Khatami; Negar Azarpira; Hamid Galehdari; Sara Pakbaz
Journal:  Mol Biol Rep       Date:  2018-08-24       Impact factor: 2.316

6.  miR-155 overexpression is followed by downregulation of its target gene, NFE2L2, and altered pattern of VEGFA expression in the liver of melanoma B16-bearing mice at the premetastatic stage.

Authors:  Mariya B Aksenenko; Nadezhda V Palkina; Olga N Sergeeva; Ekaterina Yu Sergeeva; Andrey K Kirichenko; Tatiana G Ruksha
Journal:  Int J Exp Pathol       Date:  2020-02-11       Impact factor: 1.925

7.  Cryptochromes Suppress HIF1α in Muscles.

Authors:  Megan E Vaughan; Martina Wallace; Michal K Handzlik; Alanna B Chan; Christian M Metallo; Katja A Lamia
Journal:  iScience       Date:  2020-07-03

8.  Vagus-macrophage-hepatocyte link promotes post-injury liver regeneration and whole-body survival through hepatic FoxM1 activation.

Authors:  Tomohito Izumi; Junta Imai; Junpei Yamamoto; Yohei Kawana; Akira Endo; Hiroto Sugawara; Masato Kohata; Yoichiro Asai; Kei Takahashi; Shinjiro Kodama; Keizo Kaneko; Junhong Gao; Kenji Uno; Shojiro Sawada; Vladimir V Kalinichenko; Yasushi Ishigaki; Tetsuya Yamada; Hideki Katagiri
Journal:  Nat Commun       Date:  2018-12-13       Impact factor: 14.919

Review 9.  Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression.

Authors:  Oren Tirosh
Journal:  Oxid Med Cell Longev       Date:  2018-05-31       Impact factor: 6.543

10.  Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers.

Authors:  Midori Honma; Shojiro Sawada; Yoshiyuki Ueno; Keigo Murakami; Tetsuya Yamada; Junhong Gao; Shinjiro Kodama; Tomohito Izumi; Kei Takahashi; Sohei Tsukita; Kenji Uno; Junta Imai; Eiji Kakazu; Yasuteru Kondo; Kei Mizuno; Naoki Kawagishi; Tooru Shimosegawa; Hideki Katagiri
Journal:  Int J Obes (Lond)       Date:  2018-05-01       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.